PEPTAS made-to-order material
hGH Fragment 176-191 6mg
| Catalog ID | PEP-HGH176191-006 |
|---|---|
| Molecular class | Cyclic and disulfide-bridged peptides |
| Availability | Made to order |
hGH Fragment 176-191 6mg research material identified by sequence region and intended only for laboratory research use.
Quoted per order; schedule confirmed in the quotation.
This sequence attracts interest outside laboratory research. The request form requires a stated intended research use before it can be submitted.
Prices are quoted in writing. Quantity, pack format, documentation and destination all affect the price, and each complete request is reviewed before a quotation is issued.
Larger and recurring quantities are quoted through Volume and recurring supply.
This catalog entry records chemical identity information for a laboratory research material. It is not a quotation or a commitment to supply.
Documentation for this item. Analytical documentation available for the material and batch is confirmed in the quotation. What can be requested.
Identity and procurement context
Product information
PEPTAS catalog record
About hGH Fragment 176-191 6mg
hGH Fragment 176-191 designates a peptide associated with a sequence region of human growth hormone. This PEPTAS 6mg listing is strictly for controlled research procurement. The region-based name does not establish sequence, terminal chemistry, or modifications. It must not be described or used as a medicine, diagnostic, supplement, or material for administration to a person or animal.
- Catalog item
- hGH Fragment 176-191 6mg
- Material class
- Sequence-region peptide fragment research material
- Permitted context
- Qualified laboratory research only
hGH Fragment 176-191 6mg specifications
- Physical form
- Lyophilized powder
- Purity stated on packaging
- ≥ 98.8% (HPLC)
- Storage
- Stored and shipped as stated on the packaging and in the order documentation. See Quality control.
These identifiers describe the catalog material. The molecular weight shown is the average mass calculated from the molecular formula above. The purity figure above is the specification printed on the packaging, not a result for any particular lot — batch-specific analytical documentation is confirmed for the actual item or accepted order. See Quality control.
Planning work with this material
This fragment is distinct from AOD-9604. They have separate registry numbers and differ by a single oxygen atom. They are not interchangeable, and selection must follow strict project specifications.
Confirm exact sequence, terminal form, counterion, and analytical methods before ordering. Record the sequence exactly as supplied rather than relying on the 176-191 shorthand when comparing research.
Maintain the item identifier, lot, and storage records together at receipt. Treat any conflict between labels, images, or records and the accepted order as a documentation discrepancy and contact PEPTAS.
Documentation and order review
Availability, product identity, listed quantity, price, packaging, transport terms, storage information, and any supporting analytical documents are confirmed for the actual item or accepted order. Request the information your project requires before purchasing; a general catalog page cannot replace an order-specific specification or certificate.
- Confirm purchaser eligibility, destination rules, permits, and institutional approvals.
- Define identity and analytical acceptance criteria before the material is received.
- Inspect the package, identifier, quantity, lot information, and documents on arrival.
- Maintain controlled access, storage, preparation, traceability, and disposal records.
Research-use conditions
Not for human or veterinary use. This material is not a medicine, food, dietary supplement, cosmetic, diagnostic product, or household product. It must not be administered, consumed, compounded for administration, used for self-experimentation, or represented as suitable for the diagnosis, treatment, mitigation, cure, or prevention of any condition.
Purchasers are responsible for lawful acquisition and use, competent risk assessment, suitable facilities and personnel, appropriate personal protective equipment, validated procedures, security, incident response, and waste disposal. Website information is not medical, veterinary, legal, regulatory, or scientific-protocol advice.